Avadel Pharmaceuticals Plc (AVDL) Inventory Turnover Ratio, from third quarter 2025 to third quarter 2024, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Avadel Pharmaceuticals Plc  (NASDAQ: AVDL)
 

Avadel Pharmaceuticals Plc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Avadel Pharmaceuticals Plc's inventory turnover ratio, the ratio that measures Avadel Pharmaceuticals Plc's ability to manage its supply chain, sequentially decreased to 1.78 in the third quarter 2025, which does not come as a surprise, as the Avadel Pharmaceuticals Plc continue to experience headwinds, which also impact its supply chain. Avadel Pharmaceuticals Plc's average inventory processing period in the Sep 30 2025 quarter, has increased to 205 days, from 175 days, in the Jun 30 2025 quarter.

Within Healthcare sector 239 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2025, to 1152, from total ranking in the second quarter 2025 at 1628.

AVDL Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Avadel Pharmaceuticals Plc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AVDL Inventory Turnover Ratio (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter
Y / Y Inventory Growth 33.34 % 101.97 % 78.86 % 323.04 % 1413.9 %
Y / Y Cost of Sales Growth -33.13 % 128.34 % 266.43 % 4012.82 % 16997.22 %
Inventory Turnover Ratio (TTM) 1.78 2.09 2.04 1.9 1.73
AVDL's Total Ranking # 1152 # 1628 # 1339 # 1148 # 1776
Average inventory processing period 205 175 179 192 211
Seq. Inventory Growth -0.53 % -7.04 % 27.07 % 13.48 % 50.67 %
Seq. Cost of Sales Growth -35.34 % 14.15 % 15.9 % -21.82 % 120.77 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 73
Healthcare Sector # 240
Overall Market # 1152

Inventory Turnover Ratio Statistics
High Average Low
3.58 2.01 0.59
(Mar 31 2020)   (Mar 31 2019)



AVDL Company Profile >> Back to AVDL Efficiency Comparisons >> Compare AVDL Inventory Turnover Ratio to its Competitors

Financial Statements
Avadel Pharmaceuticals Plc's Inventories $ 12 Millions Visit AVDL's Balance sheet
Avadel Pharmaceuticals Plc's Cost of Revenues TTM $ 21 Millions Visit AVDL's Income Statement
What are AVDL's Sales? Visit AVDL's Sales by Segment

Other Inventory Turnover Ratios
Avadel Pharmaceuticals Plc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
AVDL's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for AVDL's Competitors
Inventory Turnover Ratio for AVDL's Suppliers
Inventory Turnover Ratio for AVDL's Customers

You may also want to know
AVDL's Sales Growth Rates AVDL's Pe Price to earnings ratio AVDL's Receivables Turnover Ratio AVDL's Stock Quote
AVDL's Net Income Growth Rates AVDL's Ps Price to Sales ratio AVDL's Sales per Employee AVDL's Asset Turnover Ratio
AVDL's Net Margin AVDL's Pb Price to Book ratio AVDL's Financial Strength Ratios AVDL's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2025, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2025 Inventories at quarter ending Sep 30 2025
Lifeward ltd   4.82 $ 15.314  Millions$ 3  Millions
West Pharmaceutical Services Inc   4.78 $ 1,943.000  Millions$ 406  Millions
Henry Schein Inc   4.77 $ 8,903.000  Millions$ 1,868  Millions
Evolus Inc   4.74 $ 96.603  Millions$ 20  Millions
Incyte Corporation  4.69 $ 339.440  Millions$ 72  Millions
Strata Skin Sciences Inc  4.64 $ 13.000  Millions$ 3  Millions
Integrated Biopharma Inc  4.59 $ 47.000  Millions$ 10  Millions
Cryoport inc   4.41 $ 101.635  Millions$ 23  Millions
Indivior Pharmaceuticals Inc   4.39 $ 410.000  Millions$ 94  Millions
Envista Holdings Corporation  4.36 $ 1,172.000  Millions$ 269  Millions
Tactile Systems Technology Inc   4.35 $ 77.000  Millions$ 18  Millions
Celularity Inc   4.32 $ 20.043  Millions$ 5  Millions
Teva Pharmaceutical Industries Limited  4.29 $ 8,374.000  Millions$ 1,953  Millions
Inotiv Inc   4.26 $ 170.867  Millions$ 40  Millions
Novocure Limited  4.11 $ 158.188  Millions$ 38  Millions
Idexx Laboratories Inc  4.09 $ 1,596.890  Millions$ 391  Millions
Koru Medical Systems Inc   4.08 $ 14.721  Millions$ 4  Millions
Logicmark Inc  4.05 $ 3.625  Millions$ 1  Millions
Guardant Health Inc   4.05 $ 327.108  Millions$ 81  Millions
Electromed Inc   4.02 $ 13.823  Millions$ 3  Millions
Ge Healthcare Technologies Inc   3.97 $ 8,619.000  Millions$ 2,171  Millions
Alpha Teknova Inc   3.91 $ 27.248  Millions$ 7  Millions
Vericel Corporation  3.90 $ 67.747  Millions$ 17  Millions
Abbvie Inc   3.88 $ 18,048.000  Millions$ 4,651  Millions
Insight Molecular Diagnostics Inc   3.86 $ 1.964  Millions$ 1  Millions
Catalyst Pharmaceuticals Inc   3.85 $ 82.822  Millions$ 21  Millions
Dynatronics Corporation  3.84 $ 21.053  Millions$ 5  Millions
3m Company  3.77 $ 14,660.000  Millions$ 3,884  Millions
Myomo Inc   3.63 $ 13.000  Millions$ 4  Millions
Solventum Corporation  3.62 $ 3,378.000  Millions$ 934  Millions

Date modified: 2026-09-08T15:11:34+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.